Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- TU
- Uo
- I
Lists including Michael
Work Experience
2024
Member Board of Directors
2024
2024
Member Board of Directors
2024
2023
Guest to the Board
2023
2021
Member Board of Directors
2021
2020
Partner
2023
Venture Partner
2020 - 2023
2006 - 2020
SVP Head of Operations R&D & Copenhagen Site Manager
2018 - 2020
SVP Clinical Development & Copenhagen Site Manager
2010 - 2017
SVP Clinical Development
2010 - 2010
VP, Head of Development Project Management
2009 - 2010
VP - US Development Operations
2008 - 2008
Director - Project Management
2006 - 2008
Overall responsibility for two of Genmab,s Development projects
2005 - 2006
Associate
2005 - 2006
- Evaluation of clinical trial protocols and resulting data from BankInvest’s portfolio companies - Overview of established therapies per therapeutic area & market potential - Gold standards, medical need, treatment cost, market up-take - Project portfolio valuation of BankInvest’s portfolio companies; based on DCF/NPV calculations - Due Diligence in connection with new and follow-on investments; technology, clinical data, patents - Generation and implementation of re-structuring plans for one of BankInvest’s portfolio companies - Overview of Biotech / Pharma Industry landscape - M & A, licensing deals, therapeutic areas, product pipeline, development stage, clinical data
1998 - 2005
Associate - Scientific Licensing
2004 - 2005
- Identification and evaluation of new licensing opportunities within cancer inflammation - Leading of cross-functional evaluation teams - Science, strategic fit, IPR, market potential - Presenting results and recommendation to Discovery Management - Establishment of: - Strategic and collaborative alliances - In- and out licensing agreements - Agreements – Research, Consultancy and Material transfer - Participation in Discovery’s alliance implementation and management - Focus on contractual and relationship issues - Maintenance of agreements
Pharmacologist
1998 - 2005
- Design, implementation and evaluation of in vivo pharmacological studies to drive progress of discovery and early development projects - Establishment of state of the art disease models: - 1 year+ inflammation and cancer - 2 years+: obesity and type 2 diabetes - 2 years+: Growth Hormone physiology and reproduction - Initiation and monitoring of contract research projects - Scientific reporting internally and externally - Supervision and performance appraisal of reporting technical staff
1992 - 1998
Research Fellow & Associate Principle Scientist (RCDMB)
1996 - 1998
Post Doc at Research Centre for Developmental Medicine & Biology (RCDMB)
1992 - 1996